Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -12.24M
March 31, 2026 -2.83M
December 31, 2025 -4.038M
September 30, 2025 -0.911M
June 30, 2025 -1.057M
March 31, 2025 -0.33M
December 31, 2024 -4.78M
September 30, 2024 -1.747M
June 30, 2024 -1.29M
March 31, 2024 -0.624M
December 31, 2023 -0.206M
September 30, 2023 -10.48M
June 30, 2023 -0.243M
March 31, 2023 -0.364M
December 31, 2022 -0.491M
September 30, 2022 -0.094M
June 30, 2022 -0.002M
March 31, 2022 0.00
December 31, 2021 -0.02M
Date Value
September 30, 2021 0.00
June 30, 2021 -0.0348M
March 31, 2021 -0.0524M
December 31, 2020 0.961M
September 30, 2020 -0.1225M
June 30, 2020 -0.4084M
March 31, 2020 -0.1822M
December 31, 2019 -0.1339M
September 30, 2019 -0.636M
June 30, 2019 -0.8349M
March 31, 2019 -0.2453M
December 31, 2018 -0.1011M
September 30, 2018 -0.1399M
June 30, 2018 -0.3729M
March 31, 2018 -0.2571M
December 31, 2017 -1.294M
September 30, 2017 -1.039M
June 30, 2017 -0.1602M
March 31, 2017 -0.0508M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Harmony Biosciences Holdings, Inc. -131.50M
Johnson & Johnson --
United Therapeutics Corp. 87.50M
Amneal Pharmaceuticals, Inc. -123.14M
Pfizer Inc. 2.106B